WinstonWınston
Back
RHÖN-KLINIKUM Aktiengesellschaft logo

RHÖN-KLINIKUM Aktiengesellschaft

RHK.DE
40
Medical - Care Facilities · Healthcare
Exchange
Frankfurt Stock Exchange
Winston Score
40
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Weak
Growth
Mixed
Cash Flow
Weak
Stability
Exceptional
Valuation
Strong
Dividends
Weak

Winston Score History

The full picture

Rhoen-Klinikum AG is a German hospital company that runs a network of large acute-care hospitals and medical centers. It provides services like surgery, emergency care, and specialized treatments to patients across Germany. The company is one of the larger private hospital operators in Germany, with a focus on high-complexity medical care rather than routine outpatient services.

Rhoen-Klinikum earns money primarily by billing health insurers — both public and private — for the medical treatments its hospitals deliver. It operates almost entirely within Germany, and its main competitive advantage is its concentration in regional hospital hubs that handle complex cases other smaller facilities cannot. However, the company faces real pressure: its gross margin is currently negative, meaning it costs more to deliver care than it collects in direct revenues before overhead, which reflects the broader challenge German hospitals face from rising staff costs, energy prices, and reimbursement rates that have not kept pace with inflation.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+2.1% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+40.0% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

94.5%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

€566M cash & investments

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

RHÖN-KLINIKUM Aktiengesellschaft is growing revenue at 2% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
-1.2%
Thin — -1.2% gross margin
Profit after running costs
Operating Margin
2.8%
Thin — 2.8% operating margin
Return on the money invested
ROCE
3.6%
Weak — 3.6% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+4.9%
Slow sales growth (+4.9% YoY)
Profit growth
EPS YoY
+14.3%
Earnings growing (+14.3% YoY)

Healthy double-digit earnings growth — what compounders look like.

How steady the profit is
EPS Consistency
3/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
0%
Weak — only 0% of profit becomes cash
Spare cash per sale
FCF Margin
0.0%
Thin free cash flow (0.0%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.09
Conservative — low debt load (0.09)
Covers its interest
Interest Cover
17.51x
Comfortably covers interest (17.5x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
22.8x
no trend
Growth-priced — P/E 22.8

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year
P/E vs Forward
+6.2
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (22.8 → 16.6)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
1.35%
no trend
Small dividend — 1.35% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
-65.9%
no trend
Dividend cut (-65.9% YoY) — warning sign

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial